Our Team

Ajay Arora

VP and CFO International

Michael Clark

Executive Vice President - Finance

Michael Clark joined UpHealth in October 2020. He has a Bachelors and Masters of Accountancy from The University of Tampa and is a Licensed Florida CPA. Michael started his career in public accounting and has provided financial support and leadership for multiple healthcare companies prior to joining UpHealth. Currently, Michael is passionate about the growth of UpHealth to allow the company to help more individuals in need.

Jay Jennings

Chief Accounting Officer

Jay Jennings, CPA, is a seasoned accounting executive, who served as an Audit Manager at Ernst & Young and Corporate Controller for publicly-traded MetaCreations Corporation and, for more than 17 years, served as the Principal Accounting Officer for publicly-traded eHealth, Inc., a leading health insurance marketplace with a technology and service platform. In his role at eHealth, Mr. Jennings built a global finance team from five to 100 employees. He was responsible for accounting operations, revenue operations, SEC reporting, technical accounting, financial planning and analysis, business analytics, income taxes, treasury and corporate insurance/risk management programs. Mr. Jennings also managed system implementations focused on driving automation, improved analytics and cost-savings.

Matt Koehler

Vice President of Product Management

Matt Koehler is a seasoned healthcare executive with 20 years of experience in healthcare information technology, primarily focused in product management. Prior to joining UpHealth, Matt spent six years at Cambia Health Solutions, the parent company for Regence BlueCross BlueShield, leading a variety of product initiatives aimed at reimagining care management,
consumer engagement and value-based provider relationships. Matt led the team that built the new consumer digital experience that serves as the backbone for Regence’s two million members. Prior to Cambia, Matt spent three years as Vice President, Product Innovation at Surescripts where he launched the Surescripts National Record Locator product line, which now provides record locations for 320 million patients and supports 750 million document exchanges per year. Matt started his career at Kryptiq Corporation where he held a variety of product and business roles. In his last role at Kryptiq, Matt led the interoperability and network platform business and launched a 50-state immunization registry reporting solution for a top-3 Pharmacy chain. Matt holds a bachelor of sciences in electrical engineering from Oregon State University.

Jason Luchterhand

Vice President, Sales Operations

Dr. Avi Katz

Chairman, Board of Directors

Independent Chairman. Dr. Avi Katz, GigCapital’s Founder, Chairman and CEO, has spent more than 30 years holding international managerial and executive positions in the high-technology sector. He is a serial entrepreneur and angel investor with decades of experience working for companies of every size, from start-ups to global enterprises. Throughout his career, Katz has facilitated leadership team building, large-scale fundraising, initial and secondary public offering, the development of alliances and tech partnerships, mergers and acquisitions and almost every other facet of business and financial operations.
In addition to his work at GigCapital, Katz is also the Founding Managing Member of GigAcquistions, LLC; GigFounders, LLC; and GigNext, LLC. Previously, he bootstrapped in 2007 GigOptix / GigPeak. Inc., took the company public in 2008 (NYSE: GIG) and led its growth as Chairman, CEO and President through organic and strategic growth through rollup of 10 M&A deals during that time. He sold the company in April 2017 for $250 million all-cash to Integrated Device Technology (NASDAQ: IDT).
Katz is a graduate of the Israeli Naval Academy and holds both a bachelor of science degree, and a Ph.D. in Semiconductors Materials Engineering from the Technion, the Israeli Institute of Technology. He has authored more than 70 U.S. and international patents, has published more than 300 technical papers and is the editor of a number of technical books.

Dr. Raluca Dinu

Member, Board of Directors, Compliance Committee Chair

Independent Member. Dr. Raluca Dinu is a visionary and global business executive, offering 20 years of achievements in the high-tech industry (semiconductors, electronics, media, cloud data management, and information technology), with an established track record of driving increased revenue and profitability, building and leading cross-functional teams, delivering strong results in turnaround situations and leading strategic growth and consolidation in fast-paced business environments.

Dinu held a General Manager / Vice President position at Integrated Device Technology, Inc. (NASDAQ: IDTI), which was acquired by Renesas Electronics Corp (TSE 6723:JP) for $6.7B. She drove the transfer and integration of the team from GigPeak, Inc. (NYSE GIG) into IDT, post-acquisition of GigPeak by IDT in April 2017. Prior to this, she was Chief Operations Officer of GigPeak, leading 10 M&As prior to the acquisition by IDT.

Dinu is chair of the compliance committee as part of the board of directors of UpHealth, Inc., a digital healthcare company (NYSE: UPH), and she is also a member of the audit and compensation committees. Additionally, she is part of the Audit Committee of the Board of Directors of BigBear.ai (NYSE: BBAI), a company that operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. She holds a bachelor’s degree. in physics and a Ph.D. in solid state condensed matter physics from the University of Bucharest and an Executive MBA from Stanford University. She has an audit committee certificate and compensation committee certificate from Harvard Business School, Executive Education Program.

Mark J. Guinan

Member, Board of Directors, Audit Committee Chair

Independent Board member and Chairman of the Audit Committee. Mark Guinan serves on the Board of Myovant Sciences as Chair of the Audit Committee and Lead Independent Director. He recently retired from Quest Diagnostics after serving as Executive Vice President and Chief Financial Officer for nine years.

From 2010 until joining Quest Diagnostics in 2013 as Senior Vice President and Chief Financial Officer, Mark served as Chief Financial Officer for Hill-Rom Holdings Inc., a manufacturer and provider of medical technologies and related services for the health care industry. Previously, he had served in a number of finance and operations roles in a long career at Johnson & Johnson, where Mark served as Chief Procurement Officer, and earlier as Vice President of Pharmaceuticals Group Finance. Before that, he held a number of financial roles at Procter & Gamble.

Mark earned an MBA from The John M. Olin Graduate School of Business at Washington University, St. Louis, Mo., and a bachelor’s degree in economics from the University of Notre Dame.

Dr. Chirinjeev Kathuria

Member, Board of Directors

Dr. Chirinjeev Kathuria is an Indian-American investor, businessperson and philanthropist. Dr. Kathuria co-founded several leading companies in the medical field that include American Teleradiology NightHawks, Inc., Ocean Biomedical and UpHealth. American Teleradiology NightHawks, Inc. merged with NightHawk Radiology Holdings, Inc., and the combined company went public on NASDAQ. Kathuria also co-founded Ocean Biomedical, which recently announced a malaria vaccine discovery. Kathuria ran for U.S. Senate in Illinois, becoming the first Indian-American to run for the US Senate. He received a bachelor’s degree and a medical degree from Brown University and an MBA from Stanford University.

Nathan Locke

Member, Board of Directors

Independent Member. Nathan Locke is a Managing Partner and Co-Head of Kayne Anderson Capital Advisors’ growth equity activities and is also a member of the Kayne Partners Investment Committee. He has spent more than a dozen years at Kayne Anderson identifying and analyzing investment opportunities in technology and tech-enabled service companies and assisting at the board level in helping those companies as they scale post investment. He has been involved with companies at various stages of growth in healthcare technology and telemedicine, media and telecom, security and compliance and supply chain and logistics. Locke has played a leading role in building a highly experienced and diverse team of 17 professionals with over 50% being females or minorities. Together, this team has invested in over 40 companies. In 2021, the Los Angeles Business Journal listed Locke as a Leader of Influence in the private equity space.

Prior to joining Kayne Anderson in 2008, Locke worked as a senior analyst on the finance team of Romney for President, Inc., and as the controller for The Commonwealth Political Action Committees. He earned a bachelor’s degree in finance from the University of Utah, where he graduated magna cum laude from the David Eccles School of Business.

Luis Machuca

Member, Board of Directors, Nominating and Corporate Governance Committee Chair

Independent Board Member. Luis Machuca’s leadership roles span healthcare services, technology-enabled healthcare and population health management software. Machuca is a turnaround expert, former CEO of emerging growth companies and a company founder. He served as President and CEO of Enli and in senior leadership roles at Intel Corporation, as Executive Vice President of the NEC Computer Services Division of PB-NEC Corporation and as President and Chief Operating Officer of eFusion Corporation. He currently serves on the board of public and private companies, including Umpqua Bank (UMPQ) where he serves as Chairman of the Compensation Committee and Vice Chairman of the Finance and Capital Committee and as a member of the Umpqua Executive and Nominating and Governance Committees. Machuca also serves on the Board of Cambia Health Systems, a nonprofit health care company based in Portland, Ore., and a member of the Blue Cross and Blue Shield Association operating six health plans across Oregon, Washington, Idaho and Utah, providing insurance to more than three million people. Among his other Board memberships are HCAP portfolio company, Saphyre, and he is an advisory board member of HCAP portfolio companies, Chordline Health and IronRod Health. Aside from his accomplishments as a leader, he has significant experience in governance, turnarounds, mergers and acquisitions, finance, risk management and talent development.

Samuel J. Meckey

Member, Board of Directors

Samuel J. Meckey has considerable healthcare experience and a consistent track record of delivering exceptional results. He excels at building winning teams, creating a client-first culture, and driving innovation that meets the needs of the market.
 
Meckey was most recently executive vice president and Head of Healthcare at EXLService Holdings, Inc., a leading data analytics, digital operations and solutions company. During his tenure, he integrated five separate businesses into one cohesive operating unit and developed the strategic plan to double the business's size, grew revenues and net income, increased gross margin and significantly improved return on invested capital.
 
Prior to joining EXL, he was president of Optum Global Solutions, overseeing the company's global operations and technology services organization. There, Meckey was responsible for more than 35,000 employees in India, the Philippines, Brazil and the United States. Under his leadership, revenue and earnings significantly increased.
 
Before beginning his career in healthcare, Meckey was an officer and pilot in the United States Navy. He completed his undergraduate work in economics at the United States Naval Academy and earned a master's degree from Harvard Business School.

Dr. Mariya Pylypiv

Member, Board of Directors

Dr. Mariya Pylypiv is an accomplished executive, thought leader and strategist with demonstrated success across healthcare, technological services and financial services. She has deep experience in raising capital and corporate development. Pylypiv has served as VP, Investment Banking and Corporate Development for a nationwide professional services firm and developed global equity strategies for a quantitative machine learning hedge fund (AUM $350 million peak assets). Pylypiv received her Ph.D. from Purdue University with a focus on behavioral finance. She holds a master’s degree in accounting and international economics from Ternopil Academy of National Economy, a bachelor’s degree in accounting and international economics from Ternopil Academy of National Economy, and serves on several advisory boards for digital health, wellness and investment markets.

Agnes Rey-Giraud

Member, Board of Directors, Compensation Committee Chair

Independent Member. Agnès Rey-Giraud is chairman and CEO of Acera Surgical, Inc., which she co-founded in 2013. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. The proven healing power of Acera’s surgical matrices provide relief to patients who suffer from surgical wounds, trauma, burns, and chronic wounds, among other indications. Rey-Giraud played an essential role in devising Acera’s initial strategy, recruiting the company’s first leadership team and securing the financial backing to bring revolutionary concepts from the lab to the operating room.

She was previously an officer at Express Scripts (NASDAQ : ESRX), a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including executive vice president of product development, supply chain, corporate strategy and president of international operations.

Rey-Giraud currently serves as a member of board of directors at UpHealth and chairs the compensation committee chair. She also serves on the board of GoodRx (NASDAQ : GDRX), a role she has held since 2016. She has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation in 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the US that are now the common standard in the country.

Her other board roles have included Pritikin, a wellness company, and HD Smith, a privately owned drug wholesale distributor.
Rey-Giraud is a cancer survivor who credits a clinical trial with her life-saving treatment. She has since become an advocate for breast cancer awareness and affordable health care, especially for patients diagnosed with debilitating or terminal illness.
She holds an MBA from the University of Chicago, a master of management in operations from Ecole de Management de Lyon Business School, one of France’s leading universities, and a master’s degree in engineering, also earned in France. She has earned certifications in board service from Northwestern University and Harvard University.

She and her wife live in Colorado where they enjoy hiking, biking and the magnificence of wildlife and the outdoors.